Zubrinich CM[au] - Search Results

Year	Number of Results
2007	1
2008	1
2013	2
2014	1
2016	1
2018	3
2019	1
2020	1
2021	2
2022	0

1

Strongyloides infection as a reversible cause of chronic urticaria.

Zubrinich CM, Puy RM, O'Hehir RE, Hew M. Zubrinich CM, et al. J Asthma Allergy. 2019 Feb 26;12:67-69. doi: 10.2147/JAA.S167292. eCollection 2019. J Asthma Allergy. 2019. PMID: 30881049 Free PMC article.

2

A Survey on Knowledge Gaps in Assessment and Management of Severe Drug Hypersensitivity Reactions: Multicenter Cross-Sectional Study of Australian Health Care Providers.

Mazzoni D, Tee HW, de Menezes SL, Graudins LV, Johnson DF, Newnham ED, Kelley PG, Zubrinich CM, Goh MSY, Trubiano JA, Aung AK. Mazzoni D, et al. Among authors: zubrinich cm. J Clin Pharmacol. 2021 Jan;61(1):25-31. doi: 10.1002/jcph.1692. Epub 2020 Jul 10. J Clin Pharmacol. 2021. PMID: 32648298

3

Combination treatment with monoclonal antibodies: Secukinumab, benralizumab and dupilumab for the combined management of psoriasis and severe asthma.

Mahar PD, Zubrinich CM, Manuelpillai N, Foley P. Mahar PD, et al. Among authors: zubrinich cm. Australas J Dermatol. 2021 Nov;62(4):506-508. doi: 10.1111/ajd.13676. Epub 2021 Aug 9. Australas J Dermatol. 2021. PMID: 34370309

4

Epidemic Thunderstorm Asthma Protection with Five-Grass Pollen Tablet Sublingual Immunotherapy: A Clinical Trial.

O'Hehir RE, Varese NP, Deckert K, Zubrinich CM, van Zelm MC, Rolland JM, Hew M. O'Hehir RE, et al. Among authors: zubrinich cm. Am J Respir Crit Care Med. 2018 Jul 1;198(1):126-128. doi: 10.1164/rccm.201711-2337LE. Am J Respir Crit Care Med. 2018. PMID: 29461859 Clinical Trial. No abstract available.

5

Medication-related anaphylaxis treated in hospital: Agents implicated, patient outcomes, and management lessons.

Graudins LV, Trubiano JA, Zubrinich CM, Elliott AS, Aung AK. Graudins LV, et al. Among authors: zubrinich cm. Pharmacoepidemiol Drug Saf. 2018 Sep;27(9):1029-1033. doi: 10.1002/pds.4587. Epub 2018 Jul 27. Pharmacoepidemiol Drug Saf. 2018. PMID: 30051944

6

Adverse Drug Reactions Reported by Healthcare Professionals: Reaction Characteristics and Time to Reporting.

Aung AK, Tang MJ, Adler NR, de Menezes SL, Goh MSY, Tee HW, Trubiano JA, Puy R, Zubrinich CM, Graudins LV. Aung AK, et al. Among authors: zubrinich cm. J Clin Pharmacol. 2018 Oct;58(10):1332-1339. doi: 10.1002/jcph.1148. Epub 2018 May 7. J Clin Pharmacol. 2018. PMID: 29733431

7

Tako-tsubo-like cardiomyopathy after EpiPen administration.

Zubrinich CM, Farouque HM, Rochford SE, Sutherland MF. Zubrinich CM, et al. Intern Med J. 2008 Nov;38(11):862-5. doi: 10.1111/j.1445-5994.2008.01748.x. Intern Med J. 2008. PMID: 19120537

8

Asthma mortality in Australia in the 21st century: a case series analysis.

Goeman DP, Abramson MJ, McCarthy EA, Zubrinich CM, Douglass JA. Goeman DP, et al. Among authors: zubrinich cm. BMJ Open. 2013 May 28;3(5):e002539. doi: 10.1136/bmjopen-2012-002539. BMJ Open. 2013. PMID: 23793664 Free PMC article.

9

Intractable shellfish anaphylaxis: sensitization by cross-reactive substances in a complementary "immune stimulant" and acrylic nails.

Rolland JM, Varese N, Zubrinich CM, O'Hehir RE. Rolland JM, et al. Among authors: zubrinich cm. Ann Allergy Asthma Immunol. 2013 Mar;110(3):211-2. doi: 10.1016/j.anai.2012.12.024. Epub 2013 Jan 29. Ann Allergy Asthma Immunol. 2013. PMID: 23548538 No abstract available.

10

Airline policies for passengers with nut allergies flying from Melbourne Airport.

Stojanovic S, Zubrinich CM, O'Hehir R, Hew M. Stojanovic S, et al. Among authors: zubrinich cm. Med J Aust. 2016 Sep 19;205(6):270. doi: 10.5694/mja16.00384. Med J Aust. 2016. PMID: 27627938 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results